FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898855232> ?p ?o ?g. }

• W2898855232 endingPage "e0206705" @default.
• W2898855232 startingPage "e0206705" @default.
• W2898855232 abstract "Background Antihypertensive treatments have been shown to reduce the risk of Alzheimer’s disease (AD). The renin-angiotensin system (RAS) has been implicated in AD, and thus RAS-acting AHTs (angiotensin converting enzyme inhibitors (ACEIs), and angiotensin-II receptor blockers (ARBs)) may offer differential and additional protective benefits against AD compared with other AHTs, in addition to hypertension management. Methods In a retrospective cohort design, we examined the medical and pharmacy claims of a 20% sample of Medicare beneficiaries from 2007 to 2013, and compared rates of AD diagnosis for 1,343,334 users of six different AHT drug treatments, 65 years of age or older (4,215,338 person-years). We compared AD risk between RAS and non-RAS AHT drug users, and between ACEI users and ARB users, by sex and race/ethnicity. Models adjusted for age, socioeconomic status, underlying health, and comorbidities. Findings RAS-acting AHTs were slightly more protective against onset of AD than non-RAS-acting AHTs for males, (male OR = 0.931 (CI: 0.895–0.969)), but not so for females (female OR = 0.985 (CI: 0.963–1.007)). Relative to other AHTs, ARBs were superior to ACEIs for both men (male ARB OR = 0.834 (CI: 0.788–0.884); male ACEI OR = 0.978 (CI: 0.939–1.019)) and women (female ARB OR = 0.941 (CI: 0.913–0.969); female ACEI OR = 1.022 (CI: 0.997–1.048)), but only in white men and white and black women. No association was shown for Hispanic men and women. Conclusion Hypertension management treatments that include RAS-acting ARBs may, in addition to lowering blood pressure, reduce AD risk, particularly for white and black women and white men. Additional studies and clinical trials that include men and women from different racial and ethnic groups are needed to confirm these findings. Understanding the potentially beneficial effects of certain RAS-acting AHTs in high-risk populations is of great importance." @default.
• W2898855232 created "2018-11-09" @default.
• W2898855232 creator A5007377929 @default.
• W2898855232 creator A5027119794 @default.
• W2898855232 creator A5037073884 @default.
• W2898855232 creator A5043413586 @default.
• W2898855232 creator A5064356792 @default.
• W2898855232 date "2018-11-01" @default.
• W2898855232 modified "2023-10-11" @default.
• W2898855232 title "The association of multiple anti-hypertensive medication classes with Alzheimer’s disease incidence across sex, race, and ethnicity" @default.
• W2898855232 cites W1555463606 @default.
• W2898855232 cites W1569630040 @default.
• W2898855232 cites W1828947725 @default.
• W2898855232 cites W1835154286 @default.
• W2898855232 cites W1898219529 @default.
• W2898855232 cites W1903618807 @default.
• W2898855232 cites W1967645451 @default.
• W2898855232 cites W1977665419 @default.
• W2898855232 cites W1981132320 @default.
• W2898855232 cites W1981802311 @default.
• W2898855232 cites W1982717642 @default.
• W2898855232 cites W1999061258 @default.
• W2898855232 cites W2000093141 @default.
• W2898855232 cites W2000949542 @default.
• W2898855232 cites W2009194462 @default.
• W2898855232 cites W2023943834 @default.
• W2898855232 cites W2031148567 @default.
• W2898855232 cites W2037581474 @default.
• W2898855232 cites W2041848287 @default.
• W2898855232 cites W2046212966 @default.
• W2898855232 cites W2053310281 @default.
• W2898855232 cites W2073735186 @default.
• W2898855232 cites W2075399370 @default.
• W2898855232 cites W2076393535 @default.
• W2898855232 cites W2077595053 @default.
• W2898855232 cites W2094294849 @default.
• W2898855232 cites W2098900970 @default.
• W2898855232 cites W2104565625 @default.
• W2898855232 cites W2115836576 @default.
• W2898855232 cites W2125008708 @default.
• W2898855232 cites W2128387720 @default.
• W2898855232 cites W2138346186 @default.
• W2898855232 cites W2145875145 @default.
• W2898855232 cites W2160547085 @default.
• W2898855232 cites W2165146299 @default.
• W2898855232 cites W2166055952 @default.
• W2898855232 cites W2324980061 @default.
• W2898855232 cites W2429791019 @default.
• W2898855232 cites W2461241125 @default.
• W2898855232 cites W2505483170 @default.
• W2898855232 cites W2550336455 @default.
• W2898855232 cites W2551207780 @default.
• W2898855232 cites W2565815646 @default.
• W2898855232 cites W2736307756 @default.
• W2898855232 cites W2765189085 @default.
• W2898855232 cites W2766163873 @default.
• W2898855232 cites W2768267412 @default.
• W2898855232 cites W2768827605 @default.
• W2898855232 cites W2773442741 @default.
• W2898855232 cites W2775061891 @default.
• W2898855232 cites W2790475912 @default.
• W2898855232 cites W2792021977 @default.
• W2898855232 cites W4211028926 @default.
• W2898855232 cites W4211050998 @default.
• W2898855232 doi "https://doi.org/10.1371/journal.pone.0206705" @default.
• W2898855232 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6211717" @default.
• W2898855232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30383807" @default.
• W2898855232 hasPublicationYear "2018" @default.
• W2898855232 type Work @default.
• W2898855232 sameAs 2898855232 @default.
• W2898855232 citedByCount "54" @default.
• W2898855232 countsByYear W28988552322019 @default.
• W2898855232 countsByYear W28988552322020 @default.
• W2898855232 countsByYear W28988552322021 @default.
• W2898855232 countsByYear W28988552322022 @default.
• W2898855232 countsByYear W28988552322023 @default.
• W2898855232 crossrefType "journal-article" @default.
• W2898855232 hasAuthorship W2898855232A5007377929 @default.
• W2898855232 hasAuthorship W2898855232A5027119794 @default.
• W2898855232 hasAuthorship W2898855232A5037073884 @default.
• W2898855232 hasAuthorship W2898855232A5043413586 @default.
• W2898855232 hasAuthorship W2898855232A5064356792 @default.
• W2898855232 hasBestOaLocation W28988552321 @default.
• W2898855232 hasConcept C120665830 @default.
• W2898855232 hasConcept C121332964 @default.
• W2898855232 hasConcept C126322002 @default.
• W2898855232 hasConcept C137403100 @default.
• W2898855232 hasConcept C144024400 @default.
• W2898855232 hasConcept C149923435 @default.
• W2898855232 hasConcept C167135981 @default.
• W2898855232 hasConcept C167704817 @default.
• W2898855232 hasConcept C19165224 @default.
• W2898855232 hasConcept C2779134260 @default.
• W2898855232 hasConcept C44249647 @default.
• W2898855232 hasConcept C61511704 @default.
• W2898855232 hasConcept C71924100 @default.
• W2898855232 hasConcept C72563966 @default.
• W2898855232 hasConceptScore W2898855232C120665830 @default.

• next